Literature DB >> 14774459

The urinary excretion and biologic decay periods of radiomercury labeling a mercurial diuretic in normal and diseased man.

G BURCH, T RAY, S THREEFOOT, F J KELLY, A SVEDBERG.   

Abstract

Entities:  

Keywords:  MERCURY DIURETICS; MERCURY, RADIOACTIVE

Mesh：

Substances：

Year:  1950        PMID： 14774459      PMCID： PMC436155          DOI： 10.1172/JCI102350

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  4 in total

1.  CONCENTRATION-TIME COURSE IN THE PLASMA OF MAN OF RADIOMERCURY INTRODUCED AS A MERCURIAL DIURETIC.

Authors:  S A Threefoot; C T Ray; G E Burch; J A Cronvich; J P Milnor; W Overman; W Gordon
Journal:  J Clin Invest       Date:  1949-07       Impact factor: 14.808

2.  Considerations of renal, hepatic, and extremital arteriovenous differences in concentration of radiomercury of a mercurial diuretic.

Authors:  P MILNOR; G BURCH
Journal:  J Clin Invest       Date:  1950-01       Impact factor: 14.808

3.  Influence of self-absorption volatilization, and deliquescence in counting of radioelements.

Authors:  F J KELLY; C T RAY; S A THREEFOOT; G E BURCH
Journal:  J Lab Clin Med       Date:  1950-04

4.  A micropipette for preparation of samples for counting in radiobiology.

Authors:  G BURCH; P REASER; S THREEFOOT; T RAY
Journal:  J Lab Clin Med       Date:  1950-04
  4 in total
  10 in total

1.  Diuretics: a review.

Authors:  H G LLOYD-THOMAS
Journal:  Postgrad Med J       Date:  1959-11       Impact factor: 2.401

2.  Plasma regression, distribution and excretion of radiomercury in relation to diuresis following the intravenous administration of Hg203 labelled chlormerodrin to the dog.

Authors:  R R BORGHGRAEF; R H KESSLER; R F PITTS
Journal:  J Clin Invest       Date:  1956-09       Impact factor: 14.808

3.  DISCUSSION: diuresis and diuretics.

Authors: 
Journal:  Proc R Soc Med       Date:  1956-09

4.  [The concept of insufficiency in the heart clinic and the differentiation of insufficiency of effort, with special reference to problems of clinical assessment].

Authors:  H VALENTIN
Journal:  Arch Kreislaufforsch       Date:  1956-10

5.  Urinary and fecal excretion of mercury in man following administration of mercurial diuretics.

Authors:  J GROSSMAN; R E WESTON; R A LEHMAN; J P HALPERIN; T D ULLMANN; L LEITER
Journal:  J Clin Invest       Date:  1951-11       Impact factor: 14.808

6.  Renal extraction and excretion of mercury in man following intravenously administered mercurial diuretics.

Authors:  R E WESTON; J GROSSMAN; R A LEHMAN; T D ULLMANN; J P HALPERIN; L LEITER
Journal:  J Clin Invest       Date:  1951-11       Impact factor: 14.808

7.  Kidney scanning: the clinical use of 197Hg chlormerodrin and 99m Tc iron complex.

Authors:  G D Chisholm; M M Aye
Journal:  Proc R Soc Med       Date:  1967-09

8.  The distribution of chlormerodrin (neohydrin) in tissues of the rat and dog.

Authors:  R R BORGHGRAEF; R F PITTS
Journal:  J Clin Invest       Date:  1956-01       Impact factor: 14.808

9.  Distribution of radiomercury administered as labelled chlormerodrin (neohydrin) in the kidneys of rats and dogs.

Authors:  R L GREIF; W J SULLIVAN; G S JACOBS; R F PITTS
Journal:  J Clin Invest       Date:  1956-01       Impact factor: 14.808

10.  Measurement of mercury in human urine.

Authors:  D M Goldberg; A D Clarke
Journal:  J Clin Pathol       Date:  1970-03       Impact factor: 3.411
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.